UPPSALA, Sweden, April 02, 2024 (GLOBE NEWSWIRE) Olink Holding AB (publ) (Nasdaq: OLK) today announced the availability of an open access data library consisting of over 300,000 protein-disease risk associations, giving researchers a powerful new tool for revealing the biological mechanisms underlying 106 human diseases. In April 2023, the UK Biobank Pharma Proteomics Project (UKB-PPP) released data produced from over 50,000 samples analyzed using the Olink® Explore platform. The UKB-PPP is t
UPPSALA, Sweden, Aug. 09, 2023 (GLOBE NEWSWIRE) Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the second quarter ended June 30, 2023.
UPPSALA, Sweden, May 11, 2023 (GLOBE NEWSWIRE) Olink Holding AB (publ) ("Olink") (Nasdaq: OLK) today announced its unaudited financial results for the first quarter ended March 31, 2023. Highlights
UPPSALA, Sweden, May 11, 2023 Olink Holding AB today announced its unaudited financial results for the first quarter ended March 31, 2023. Highlights First quarter 2023 revenue totaled. | May 11, 2023